Similar Articles
1221 Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy
1222 Target genes discovery through copy number alteration analysis in human hepatocellular carcinoma
1223 Mitochondrial DNA alterations and mitochondrial dysfunction in the progression of hepatocellular carcinoma
1224 Prevention of hepatocellular carcinoma in chronic viral hepatitis B and C infection
1225 131I-labeled metuximab combined with chemoembolization for unresectable hepatocellular carcinoma
1226 Added value of hepatobiliary phase gadoxetic acid-enhanced MRI for diagnosing hepatocellular carcinoma in high-risk patients
1227 Antiviral drug resistance increases hepatocellular carcinoma: A prospective decompensated cirrhosis cohort study
1228 Neutrophil-lymphocyte ratio predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation
1229 Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: Dysregulation and implications for early detection, diagnosis and therapy
1230 “Metroticket” predictor for assessing liver transplantation to treat hepatocellular carcinoma: A single-center analysis in mainland China
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA